Skip to main content
Erschienen in: European Radiology 11/2020

04.06.2020 | Imaging Informatics and Artificial Intelligence

Radiomics of MRI for pretreatment prediction of pathologic complete response, tumor regression grade, and neoadjuvant rectal score in patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation: an international multicenter study

verfasst von: Hiram Shaish, Andrew Aukerman, Rami Vanguri, Antonino Spinelli, Paul Armenta, Sachin Jambawalikar, Jasnit Makkar, Stuart Bentley-Hibbert, Armando Del Portillo, Ravi Kiran, Lara Monti, Christiana Bonifacio, Margarita Kirienko, Kevin L Gardner, Lawrence Schwartz, Deborah Keller

Erschienen in: European Radiology | Ausgabe 11/2020

Einloggen, um Zugang zu erhalten

Abstract

Objective

To investigate whether pretreatment MRI-based radiomics of locally advanced rectal cancer (LARC) and/or the surrounding mesorectal compartment (MC) can predict pathologic complete response (pCR), neoadjuvant rectal (NAR) score, and tumor regression grade (TRG).

Methods

One hundred thirty-two consecutive patients with LARC who underwent neoadjuvant chemoradiation and total mesorectal excision (TME) were retrospectively collected from 2 centers in the USA and Italy. The primary tumor and surrounding MC were segmented on the best available T2-weighted sequence (axial, coronal, or sagittal). Three thousand one hundred ninety radiomic features were extracted using a python package. The most salient radiomic features as well as MRI parameter and clinical-based features were selected using recursive feature elimination. A logistic regression classifier was built to distinguish between any 2 binned categories in the considered endpoints: pCR, NAR, and TRG. Repeated k-fold validation was performed and AUCs calculated.

Results

There were 24, 87, and 21 T4, T3, and T2 LARCs, respectively (median age 63 years, 32 to 86). For NAR and TRG, the best classification performance was obtained using both the tumor and MC segmentations. The AUCs for classifying NAR 0 versus 2, pCR, and TRG 0/1 versus 2/3 were 0.66 (95% CI, 0.60–0.71), 0.80 (95% CI, 0.74–0.85), and 0.80 (95% CI, 0.77–0.82), respectively.

Conclusion

Radiomics of pretreatment MRIs can predict pCR, TRG, and NAR score in patients with LARC undergoing neoadjuvant treatment and TME with moderate accuracy despite extremely heterogenous image data. Both the tumor and MC contain important prognostic information.

Key Points

• Machine learning of rectal cancer on images from the pretreatment MRI can predict important patient outcomes with moderate accuracy.
• The tumor and the tissue around it both contain important prognostic information.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Siegel RL, Miller KD, Jemal A (2017) Cancer statistics. CA Cancer J Clin 67:7–30CrossRef Siegel RL, Miller KD, Jemal A (2017) Cancer statistics. CA Cancer J Clin 67:7–30CrossRef
2.
Zurück zum Zitat Henley SJ, Singh SD, King J, Wilson RJ, O'Neil ME, Ryerson AB (2012) Invasive cancer incidence and survival--United States. MMWR Morb Mortal Wkly Rep 64:1353–1358CrossRef Henley SJ, Singh SD, King J, Wilson RJ, O'Neil ME, Ryerson AB (2012) Invasive cancer incidence and survival--United States. MMWR Morb Mortal Wkly Rep 64:1353–1358CrossRef
3.
Zurück zum Zitat Kasi PM, Shahjehan F, Cochuyt JJ, Li Z, Colibaseanu DT, Merchea A (2019) Rising proportion of young individuals with rectal and colon cancer. Clin Colorectal Cancer 18:e87–e95CrossRef Kasi PM, Shahjehan F, Cochuyt JJ, Li Z, Colibaseanu DT, Merchea A (2019) Rising proportion of young individuals with rectal and colon cancer. Clin Colorectal Cancer 18:e87–e95CrossRef
4.
Zurück zum Zitat Benson AB, Venook AP, Al-Hawary MM et al (2018) Rectal cancer, version 2.2018, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 16:874–901CrossRef Benson AB, Venook AP, Al-Hawary MM et al (2018) Rectal cancer, version 2.2018, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 16:874–901CrossRef
5.
Zurück zum Zitat Maas M, Beets-Tan RG, Lambregts DM et al (2011) Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. J Clin Oncol 29:4633–4640CrossRef Maas M, Beets-Tan RG, Lambregts DM et al (2011) Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. J Clin Oncol 29:4633–4640CrossRef
6.
Zurück zum Zitat Habr-Gama A, Perez RO, Nadalin W et al (2004) Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg 240:711–717 discussion 7-8PubMedPubMedCentral Habr-Gama A, Perez RO, Nadalin W et al (2004) Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg 240:711–717 discussion 7-8PubMedPubMedCentral
7.
Zurück zum Zitat Maas M, Nelemans PJ, Valentini V et al (2010) Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol 11:835–844CrossRef Maas M, Nelemans PJ, Valentini V et al (2010) Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol 11:835–844CrossRef
8.
Zurück zum Zitat Taylor FG, Quirke P, Heald RJ et al (2011) Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone: a prospective, multicenter, European study. Ann Surg 253:711–719CrossRef Taylor FG, Quirke P, Heald RJ et al (2011) Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone: a prospective, multicenter, European study. Ann Surg 253:711–719CrossRef
9.
Zurück zum Zitat Chadi SA, Malcomson L, Ensor J et al (2018) Factors affecting local regrowth after watch and wait for patients with a clinical complete response following chemoradiotherapy in rectal cancer (InterCoRe consortium): an individual participant data meta-analysis. Lancet Gastroenterol Hepatol 3:825–836CrossRef Chadi SA, Malcomson L, Ensor J et al (2018) Factors affecting local regrowth after watch and wait for patients with a clinical complete response following chemoradiotherapy in rectal cancer (InterCoRe consortium): an individual participant data meta-analysis. Lancet Gastroenterol Hepatol 3:825–836CrossRef
10.
Zurück zum Zitat Battersby NJ, How P, Moran B et al (2016) Prospective validation of a low rectal cancer magnetic resonance imaging staging system and development of a local recurrence risk stratification model: the MERCURY II study. Ann Surg 263:751–760CrossRef Battersby NJ, How P, Moran B et al (2016) Prospective validation of a low rectal cancer magnetic resonance imaging staging system and development of a local recurrence risk stratification model: the MERCURY II study. Ann Surg 263:751–760CrossRef
11.
Zurück zum Zitat Gillies RJ, Kinahan PE, Hricak H (2016) Radiomics: images are more than pictures, they are data. Radiology 278:563–577CrossRef Gillies RJ, Kinahan PE, Hricak H (2016) Radiomics: images are more than pictures, they are data. Radiology 278:563–577CrossRef
12.
Zurück zum Zitat Wu J, Tha KK, Xing L, Li R (2018) Radiomics and radiogenomics for precision radiotherapy. J Radiat Res 59:i25–i31CrossRef Wu J, Tha KK, Xing L, Li R (2018) Radiomics and radiogenomics for precision radiotherapy. J Radiat Res 59:i25–i31CrossRef
13.
Zurück zum Zitat Cui Y, Yang X, Shi Z et al (2019) Radiomics analysis of multiparametric MRI for prediction of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Eur Radiol 29:1211–1220CrossRef Cui Y, Yang X, Shi Z et al (2019) Radiomics analysis of multiparametric MRI for prediction of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Eur Radiol 29:1211–1220CrossRef
15.
Zurück zum Zitat Giannini V, Mazzetti S, Bertotto I et al (2019) Predicting locally advanced rectal cancer response to neoadjuvant therapy with (18)F-FDG PET and MRI radiomics features. Eur J Nucl Med Mol Imaging 46:878–888CrossRef Giannini V, Mazzetti S, Bertotto I et al (2019) Predicting locally advanced rectal cancer response to neoadjuvant therapy with (18)F-FDG PET and MRI radiomics features. Eur J Nucl Med Mol Imaging 46:878–888CrossRef
16.
Zurück zum Zitat Shi L, Zhang Y, Nie K et al (2019) Machine learning for prediction of chemoradiation therapy response in rectal cancer using pre-treatment and mid-radiation multi-parametric MRI. Magn Reson Imaging 61:33–40CrossRef Shi L, Zhang Y, Nie K et al (2019) Machine learning for prediction of chemoradiation therapy response in rectal cancer using pre-treatment and mid-radiation multi-parametric MRI. Magn Reson Imaging 61:33–40CrossRef
17.
Zurück zum Zitat George TJ Jr, Allegra CJ, Yothers G (2015) Neoadjuvant rectal (NAR) score: a new surrogate endpoint in rectal cancer clinical trials. Curr Colorectal Cancer Rep 11:275–280 George TJ Jr, Allegra CJ, Yothers G (2015) Neoadjuvant rectal (NAR) score: a new surrogate endpoint in rectal cancer clinical trials. Curr Colorectal Cancer Rep 11:275–280
18.
Zurück zum Zitat Fokas E, Fietkau R, Hartmann A et al (2018) German Rectal Cancer Study G: neoadjuvant rectal score as individual-level surrogate for disease-free survival in rectal cancer in the CAO/ARO/AIO-04 randomized phase III trial. Ann Oncol 29:1521–1527CrossRef Fokas E, Fietkau R, Hartmann A et al (2018) German Rectal Cancer Study G: neoadjuvant rectal score as individual-level surrogate for disease-free survival in rectal cancer in the CAO/ARO/AIO-04 randomized phase III trial. Ann Oncol 29:1521–1527CrossRef
19.
Zurück zum Zitat Rosello S, Frasson M, Garcia-Granero E et al (2018) Integrating downstaging in the risk assessment of patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy: validation of Valentini’s nomograms and the Neoadjuvant rectal score. Clin Colorectal Cancer 17:104–12 e2CrossRef Rosello S, Frasson M, Garcia-Granero E et al (2018) Integrating downstaging in the risk assessment of patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy: validation of Valentini’s nomograms and the Neoadjuvant rectal score. Clin Colorectal Cancer 17:104–12 e2CrossRef
20.
Zurück zum Zitat Sclafani F, Kalaitzaki E, Cunningham D, Tait D, Brown G, Chau I (2018) Neoadjuvant rectal score: run with the hare and hunt with the hounds. Ann Oncol 29:2261–2262CrossRef Sclafani F, Kalaitzaki E, Cunningham D, Tait D, Brown G, Chau I (2018) Neoadjuvant rectal score: run with the hare and hunt with the hounds. Ann Oncol 29:2261–2262CrossRef
21.
Zurück zum Zitat Dworak O, Keilholz L, Hoffmann A (1997) Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis 12:19–23CrossRef Dworak O, Keilholz L, Hoffmann A (1997) Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis 12:19–23CrossRef
22.
Zurück zum Zitat van Griethuysen JJM, Fedorov A, Parmar C et al (2017) Computational radiomics system to decode the radiographic phenotype. Cancer Res 77:e104–e1e7CrossRef van Griethuysen JJM, Fedorov A, Parmar C et al (2017) Computational radiomics system to decode the radiographic phenotype. Cancer Res 77:e104–e1e7CrossRef
23.
Zurück zum Zitat Zwanenburg A, Leger S, Agolli L et al (2019) Assessing robustness of radiomic features by image perturbation. Sci Rep 9:614CrossRef Zwanenburg A, Leger S, Agolli L et al (2019) Assessing robustness of radiomic features by image perturbation. Sci Rep 9:614CrossRef
24.
Zurück zum Zitat Horvat N, Veeraraghavan H, Khan M et al (2018) MR imaging of rectal cancer: radiomics analysis to assess treatment response after neoadjuvant therapy. Radiology 287:833–843CrossRef Horvat N, Veeraraghavan H, Khan M et al (2018) MR imaging of rectal cancer: radiomics analysis to assess treatment response after neoadjuvant therapy. Radiology 287:833–843CrossRef
25.
Zurück zum Zitat Jeon SH, Song C, Chie EK et al (2019) Delta-radiomics signature predicts treatment outcomes after preoperative chemoradiotherapy and surgery in rectal cancer. Radiat Oncol 14:43CrossRef Jeon SH, Song C, Chie EK et al (2019) Delta-radiomics signature predicts treatment outcomes after preoperative chemoradiotherapy and surgery in rectal cancer. Radiat Oncol 14:43CrossRef
26.
Zurück zum Zitat Zhou X, Yi Y, Liu Z et al (2019) Radiomics-based pretherapeutic prediction of non-response to neoadjuvant therapy in locally advanced rectal cancer. Ann Surg Oncol 26:1676–1684CrossRef Zhou X, Yi Y, Liu Z et al (2019) Radiomics-based pretherapeutic prediction of non-response to neoadjuvant therapy in locally advanced rectal cancer. Ann Surg Oncol 26:1676–1684CrossRef
27.
Zurück zum Zitat Braman NM, Etesami M, Prasanna P et al (2017) Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI. Breast Cancer Res 19:57CrossRef Braman NM, Etesami M, Prasanna P et al (2017) Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI. Breast Cancer Res 19:57CrossRef
Metadaten
Titel
Radiomics of MRI for pretreatment prediction of pathologic complete response, tumor regression grade, and neoadjuvant rectal score in patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation: an international multicenter study
verfasst von
Hiram Shaish
Andrew Aukerman
Rami Vanguri
Antonino Spinelli
Paul Armenta
Sachin Jambawalikar
Jasnit Makkar
Stuart Bentley-Hibbert
Armando Del Portillo
Ravi Kiran
Lara Monti
Christiana Bonifacio
Margarita Kirienko
Kevin L Gardner
Lawrence Schwartz
Deborah Keller
Publikationsdatum
04.06.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 11/2020
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-020-06968-6

Weitere Artikel der Ausgabe 11/2020

European Radiology 11/2020 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

13.04.2024 Klinik aktuell Kongressbericht

Die Teilnehmer eines Forums beim DGIM-Kongress waren sich einig: Fehler in der Medizin sind häufig in ungeeigneten Prozessen und mangelnder Kommunikation begründet. Gespräche mit Patienten und im Team können helfen.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.